Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $25,807 | 1,306 | 86.4% |
| Gift | $2,733 | 2 | 9.2% |
| Education | $530.05 | 23 | 1.8% |
| Travel and Lodging | $409.91 | 3 | 1.4% |
| Consulting Fee | $150.00 | 1 | 0.5% |
| Honoraria | $150.00 | 1 | 0.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $87.90 | 5 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $5,165 | 154 | $0 (2024) |
| Biogen, Inc. | $3,057 | 161 | $0 (2024) |
| EMD Serono, Inc. | $3,006 | 116 | $0 (2024) |
| Amgen Inc. | $1,622 | 50 | $0 (2024) |
| ABBVIE INC. | $1,349 | 92 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $1,248 | 37 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,185 | 70 | $0 (2024) |
| GENZYME CORPORATION | $1,173 | 58 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $1,015 | 70 | $0 (2022) |
| LivaNova USA, Inc. | $895.87 | 11 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,727 | 216 | EMD Serono, Inc. ($731.02) |
| 2023 | $3,826 | 220 | EMD Serono, Inc. ($671.10) |
| 2022 | $4,236 | 227 | EMD Serono, Inc. ($653.82) |
| 2021 | $4,443 | 209 | Biogen, Inc. ($724.36) |
| 2020 | $2,597 | 131 | Novartis Pharmaceuticals Corporation ($361.63) |
| 2019 | $5,405 | 143 | Novartis Pharmaceuticals Corporation ($3,042) |
| 2018 | $3,793 | 158 | LivaNova USA, Inc. ($825.67) |
| 2017 | $841.04 | 37 | Jazz Pharmaceuticals Inc. ($156.70) |
All Payment Transactions
1,341 individual payment records from CMS Open Payments — Page 1 of 54
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Boston Scientific Corporation | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $38.16 | General |
| Category: WATCHMAN Pro_IC | ||||||
| 12/20/2024 | Merz Pharmaceuticals, LLC | INBRIJA (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: Parkinson's Disease | ||||||
| 12/20/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $10.65 | General |
| Category: Neurology | ||||||
| 12/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: Neuropsychiatry | ||||||
| 12/12/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $29.55 | General |
| Category: Neurology | ||||||
| 12/12/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $20.73 | General |
| Category: NEUROLOGY | ||||||
| 12/12/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $7.63 | General |
| Category: Immunology | ||||||
| 12/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $6.53 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/11/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Food and Beverage | Cash or cash equivalent | $115.25 | General |
| Category: Neurology | ||||||
| 12/06/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $26.32 | General |
| Category: Neuropsychiatry | ||||||
| 12/04/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $10.59 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/22/2024 | Vanda Pharmaceuticals Inc. | PONVORY (Drug) | Food and Beverage | In-kind items and services | $35.87 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 11/21/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Neuroscience | ||||||
| 11/19/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $28.80 | General |
| Category: Neurology | ||||||
| 11/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $2.59 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/18/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Neurology | ||||||
| 11/18/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $8.48 | General |
| Category: Neurology | ||||||
| 11/16/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $28.56 | General |
| Category: Neurology | ||||||
| 11/15/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $9.10 | General |
| Category: Neuropsychiatry | ||||||
| 11/15/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $4.80 | General |
| Category: Neuropsychiatry | ||||||
| 11/14/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $32.21 | General |
| Category: NEUROLOGY | ||||||
| 11/14/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: Immunology | ||||||
| 11/12/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $30.66 | General |
| 11/08/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 678 | 895 | $271,960 | $108,936 |
| 2022 | 8 | 697 | 941 | $283,224 | $115,554 |
| 2021 | 8 | 680 | 872 | $264,079 | $111,641 |
| 2020 | 6 | 322 | 407 | $120,432 | $48,116 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 246 | 446 | $130,365 | $56,895 | 43.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 168 | 168 | $69,720 | $26,089 | 37.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 56 | 68 | $14,960 | $5,826 | 38.9% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 73 | 75 | $15,624 | $5,665 | 36.3% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 41 | 42 | $16,968 | $5,150 | 30.4% |
| 95887 | Needle measurement of electrical activity in trunk or head muscles | Office | 2023 | 71 | 73 | $11,972 | $4,832 | 40.4% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 23 | 23 | $12,351 | $4,480 | 36.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 210 | 427 | $125,111 | $55,746 | 44.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 148 | 148 | $61,199 | $23,304 | 38.1% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 98 | 104 | $21,390 | $8,352 | 39.0% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 51 | 55 | $22,220 | $7,421 | 33.4% |
| 95887 | Needle measurement of electrical activity in trunk or head muscles | Office | 2022 | 96 | 100 | $16,400 | $7,009 | 42.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 49 | 62 | $13,640 | $5,491 | 40.3% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2022 | 28 | 28 | $15,036 | $5,428 | 36.1% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 17 | 17 | $8,228 | $2,803 | 34.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 190 | 374 | $109,582 | $50,785 | 46.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 144 | 144 | $59,760 | $23,454 | 39.2% |
| 95910 | Nerve transmission studies, 7-8 studies | Office | 2021 | 57 | 58 | $23,836 | $8,743 | 36.7% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 102 | 103 | $20,238 | $8,533 | 42.2% |
| 95887 | Needle measurement and recording of electrical activity of head or trunk muscles | Office | 2021 | 100 | 101 | $16,892 | $7,242 | 42.9% |
| 95912 | Nerve transmission studies, 11-12 studies | Office | 2021 | 27 | 27 | $14,499 | $5,635 | 38.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 43 | 48 | $10,560 | $4,607 | 43.6% |
| 95911 | Nerve transmission studies, 9-10 studies | Office | 2021 | 17 | 17 | $8,712 | $2,641 | 30.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 112 | 192 | $55,474 | $22,209 | 40.0% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 88 | 88 | $36,520 | $14,534 | 39.8% |
About Dr. Timothy Allen, MD
Dr. Timothy Allen, MD is a Neurology healthcare provider based in Fort Collins, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/26/2005. The National Provider Identifier (NPI) number assigned to this provider is 1164425898.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Timothy Allen, MD has received a total of $29,868 in payments from pharmaceutical and medical device companies, with $4,727 received in 2024. These payments were reported across 1,341 transactions from 63 companies. The most common payment nature is "Food and Beverage" ($25,807).
As a Medicare-enrolled provider, Allen has provided services to 2,377 Medicare beneficiaries, totaling 3,115 services with total Medicare billing of $384,247. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location Fort Collins, CO
- Active Since 05/26/2005
- Last Updated 02/06/2026
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1164425898
Products in Payments
- GILENYA (Drug) $3,079
- TYSABRI (Biological) $1,963
- KESIMPTA (Drug) $1,630
- Aimovig (Biological) $1,562
- BOTOX (Biological) $1,072
- ZEPOSIA (Drug) $1,058
- AUBAGIO (Drug) $951.83
- VNS Therapy (Device) $937.14
- APTIOM (Drug) $907.16
- NURTEC ODT (Drug) $873.13
- ACTHAR (Biological) $838.03
- INGREZZA (Drug) $631.50
- Mavenclad (Drug) $418.32
- MAVENCLAD (Drug) $397.83
- VUMERITY (Drug) $388.75
- QULIPTA (Drug) $382.47
- SOLIRIS (Drug) $371.14
- Fintepla (Drug) $367.39
- Soliris (Drug) $349.52
- UBRELVY (Drug) $332.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Fort Collins
Dr. Jill Olson, Md, MD
Neurology — Payments: $70,600
Andrew Smith, M.d, M.D
Neurology — Payments: $65,482
Dr. Gerald Mcintosh, Md, MD
Neurology — Payments: $1,697
Dr. Brenda George, D.o, D.O
Neurology — Payments: $1,630
Dr. Jessica Williams, M.d, M.D
Neurology — Payments: $1,520
Dr. Brian Kaiser, D.o, D.O
Neurology — Payments: $1,092